Indeed, patients with pathological complete response (pCR) after NAC were reported to have more favourable long-term outcomes,8,9 especially for HER2-positive and triple-negative BC (TNBC).10 However, a minority of tumours reach pCR after NAC. This evidence concerns the gene ERBB2 and neoplasm.